Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

September 30, 2014

Conditions
Lymphoma, Large B-cell, Diffuse
Interventions
DRUG

rituximab

A dose of 375mg/m2 rituximab will be administered intravenously on day 1 of first to fourth R-CHOP chemotherapy and on day 1, 8, 15, 22 of each augmentation chemotherapy.

Trial Locations (1)

519-809

RECRUITING

Chonnam National University Hwasun Hosptial, Jeollanam-do

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Samsung Medical Center

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Severance Hospital

OTHER

lead

Chonnam National University Hospital

OTHER